VENOMAB IVS: Financial statements 2016
CVR: 35632271
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
VENOMAB IVS (CVR 35632271) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -6,817 the year before. Equity in the 2016 report amounted to DKK 14,518. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 14,518
- Total Assets
- DKK 14,518
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 0 | 0 | 0 | 15 t. | - |
| 2015 | 0 | -7 t. | -7 t. | 7 t. | - |
| 2014 | 0 | 0 | 0 | 14 t. | - |
Official annual report
Find more companies like VENOMAB IVS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
VENOMAB IVS has published its annual report for 2015. Revenue came to DKK 0, and the net result was DKK -6,817.
About VENOMAB IVS
VENOMAB IVS was a Danish company of the type Iværksætterselskab based in København N, founded in 2014. The company has been dissolved on 18 January 2018. The company was registered under the industry Uoplyst. In 2016, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -6,817 the year before. Equity in the 2016 report amounted to DKK 14,518.